Lanka Hospitals Corp. Plc
LHCL.N0000Healthcare · Hospital/Nursing Management
Annual fundamentals
| Year | Revenue | Net profit | EPS |
|---|---|---|---|
| 2025 | Rs 14.5B | Rs 1.9B | 8.69 |
| 2024 | Rs 13.7B | Rs 1.3B | 5.99 |
| 2023 | Rs 12.4B | Rs 1.3B | 6.01 |
| 2022 | Rs 10.7B | Rs 3.2B | 14.51 |
| 2021 | Rs 10.0B | Rs 2.2B | 9.88 |
| 2020 | Rs 6.8B | Rs 385.0M | 1.72 |
| 2019 | Rs 7.5B | Rs 580.6M | 2.60 |
Recent dividends
- 2025 · finalRs 1.00
- 2026Rs 10.00
- 2025 · first interimRs 2.00
- 2024 · finalRs 1.50
- 2023 · first interimRs 1.50
- 2022 · second interimRs 1.50
- 2022 · first interimRs 2.00
- 2021 · second interimRs 1.00
About Lanka Hospitals Corp. Plc
The Lanka Hospitals Corporation PLC operates a multi‑speciality tertiary care hospital and related healthcare services in Sri Lanka, delivering inpatient and outpatient medical and surgical care across more than 17 specialties from a 367‑bed facility. Clinical offerings include general and specialist surgery, cardiac care, kidney care and transplants, neurology, radiology and nuclear medicine, orthopaedics, urology and vascular surgery, alongside emergency and trauma services. The Group also operates accredited diagnostic laboratory and pharmacy businesses and a learning academy; its laboratory network is CAP and SLAB accredited and offers a comprehensive portfolio of tests, while pharmacy services include on‑site dispensing and a network of retail pharmacies. The Group’s reporting boundary includes its subsidiary, Lanka Hospital Diagnostics (Private) Ltd, and its operations are limited to Sri Lanka. Services described in the Report include new care pathways such as a home care service and a dedicated trauma care facility, supported by ongoing investments in clinical governance, technology and facility upgrades to enhance patient access and care delivery.
AI analysis
No AI research report for Lanka Hospitals Corp. Plc yet. Generate one from everything we track: prices, valuation, news sentiment, financials and corporate actions.
Generate an analysis →News sentiment
Describes news flow, not a forecast1 article in 30 days: 0 positive, 0 negative, 1 neutral.
Dividend · Rs 1.00 · XD Jun 3, 2026
Final dividend of LKR 1/share; XD 2026-06-03; record 2026-06-03; payable 2026-06-22; FY 31-12-2025
Dividend · Rs 2.00 · XD Jan 6, 2026
First Interim dividend of LKR 2/share; XD 2026-01-06; record 2026-01-06; payable 2026-01-26; FY 31-12-2025
Healthcare sector: what is happening
Last 30 days to Aug 4, 2026SLPMA dominated sector news, urging a long-term government buyback to back local pharma manufacturing, quicker raw-material import approvals and stable incentives, plus a national push to make pharmaceuticals an export engine through a task force and faster regulation. Cross-border activity featured a 31-member Indian delegation on 8-10 July for B2B sessions including pharma. Colombo Port City moved to seek operators for an international hospital. Cybersecurity risks to hospitals gained attention.
The stories behind it
Auto-generated from 8 sector news articles over 30 days. Not investment advice. 2 more stories on the sentiment page.